Trigeminal neuralgia (TN) is a painful condition characterised by severe electric shock-like or burning pain in the craniofacial tissues that connect to the trigeminal nerve.
Anne, a 52 year old with TN, seeks treatment for chronic facial pain with regular nightly flare ups. Due to the pain, Anne’s been feeling nauseated and finding it difficult to sleep, and hasn’t been able to fully participate in daily life.
Despite trialling and using a range of conventional medications, and regularly consulting specialists, Anne hasn’t found relief for her symptoms. She’s considering medical cannabis to manage her pain, nausea and sleep so she can get back to work and life.
In this case study, we explore how Anne’s team incorporated medical cannabis products in her treatment plan.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Explain the pathophysiology of trigeminal neuralgia and identify common management strategies
Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptoms of trigeminal neuralgia
Identify suitable candidates for medical cannabis treatment
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in the management of symptoms of trigeminal neuralgia
Devise treatment plans that consider patient safety and minimise risk
Offer effective patient education and treatment advice on the therapeutic use of medical cannabis
Gina, a 32-year-old with endometriosis, seeks treatment for her gastrointestinal and pain-related symptoms.
Gina has tried a range of conventional medications and therapies, but they’ve offered little relief for her symptoms, in particular her pain which leaves her cyclically incapacitated and impacts her work as a hotel manager.
In this case study, we explore how Gina’s team prescribed medical cannabis products to help Gina manage her pain and reduce the impacts on her work and wellbeing.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Explain the pathophysiology of endometriosis and identify common management strategies
Discuss the potential benefits and limitations of medical cannabis as a treatment option for common symptoms of endometriosis
Identify suitable candidates for medical cannabis treatment
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management of endometriosis
Devise treatment plans that consider patient safety and minimise risk
Offer effective patient education and treatment advice on the therapeutic use of medical cannabis
Lauren is a 35-year-old with hypermobile Ehlers-Danlos Syndrome (hEDS).
Despite currently trying to manage her symptoms with a wide range of pharmaceutical and non-pharmaceutical interventions, Lauren is still experiencing pain, sleep problems, moments of low mood and nausea. These symptoms are stopping her from being able to fully participate in life.
In this case study, we explore how Lauren's team prescribed medical cannabis products to help her manage her symptoms so she can enjoy life day-to-day.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Explain the pathophysiology of EDS and identify common management strategies
Discuss the potential benefits and limitations of medical cannabis as a treatment option for common symptoms of EDS
Identify suitable candidates for medical cannabis treatment
Devise treatment plans that consider patient safety and minimise risk
Offer effective patient education and treatment advice on the therapeutic use of medical cannabis
Chad, a 19-year-old autistic male, seeks supports to help him manage his meltdowns and secondary anxiety and depression.
Despite already implementing a wide range of supports and medications to alleviate his distress and manage his aggressive behaviour, Chad's mother Linda, is looking to medical cannabis to supplement his current plan.
In this case study, we explore how Chad's team prescribed a combination of medical cannabis products to address Chad's distress and improve his quality of life.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Define "neurotype"
Explain the purpose of neuroaffirming patient-centric practice
Identify strategies to deliver neuroaffirming practice
Explain the similarities and differences between autistic and allistic individuals
Discuss conventional treatment options for managing distress in autistic individuals
Discuss the potential benefits and limitations of medical cannabis as a treatment option for autistic individuals with anxiety and depression
Identify suitable candidates for medical cannabis treatment
Facilitate clinical discussions with patients and carers around medical cannabis as a therapeutic option for distress secondary to autistic traits
Devise treatment plans that consider patient safety and minimise risk
Offer effective patient education and treatment advice on the therapeutic use of medical cannabis
Hayley, a 37-year-old female, presents with chronic pain and combined-type ADHD.
Despite her diagnosis 27 years prior, her ADHD is unmanaged, and she’s seeking particular help with attention, anxiety and sleep, as well as pain management for chronic lower back and shoulder pain.
In this case study, we explore how Hayley’s team prescribed a combination of medical cannabis products, including medicated edibles, to treat Hayley’s symptoms and restore her quality of life.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Explain how and why ADHD and chronic pain affects patients
Discuss the potential benefits and limitations of medical cannabis as a treatment option for ADHD and pain symptoms
Identify suitable candidates for medical cannabis treatment
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in ADHD and chronic pain symptom management
Devise treatment plans that consider patient safety and minimise risk
Offer effective patient education and treatment advice on the therapeutic use of medical cannabis
Lucy, a 60-year-old female, presents with a frozen shoulder with secondary constant pain with flare ups on movement. Her quality of life is severely impacted, due to reduced range of motion in her shoulder, and she’s now unable to work. This is causing anxiety and poor sleep quality.
In this case study, we explore how Lucy’s team prescribed a combination of medical cannabis products to manage her pain symptoms and restore her quality of life.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Explain the pathophysiology of chronic pain, anxiety and sleep issues and identify common management strategies
Discuss the potential benefits and limitations of medical cannabis as a treatment option for patients with chronic pain, anxiety and sleep issues
Identify suitable candidates for medical cannabis treatment
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management of chronic pain, anxiety and sleep issues
Devise treatment plans that consider patient safety and minimise risk
Offer effective patient education and treatment advice on the therapeutic use of medical cannabis
Marta, a 49-year-old female, presents with a range of intrusive symptoms secondary to unmanaged Crohn's disease. These symptoms often interrupt Marta's work and sleep, causing anxiety.
In this case study, we explore how Marta’s team prescribed a combination of medical cannabis products to treat her symptoms and improve her quality of life.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Explain the pathophysiology of Crohn’s disease and identify common management strategies
Discuss the potential benefits and limitations of medical cannabis as a treatment option for common symptoms of Crohn’s disease
Identify suitable candidates for medical cannabis treatment
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management of symptoms of Crohn’s disease
Devise treatment plans that consider patient safety and minimise risk
Offer effective patient education and treatment advice on the therapeutic use of medical cannabis
Mario, a 40-year-old male presents with respiratory symptoms and sleep difficulties associated with his diagnosis of chronic obstructive pulmonary disease.After being hospitalised 3 times in recent months, despite following his current treatment plan, Mario is seeking a more effective solution.In this case study, we explore how Mario’s team prescribed non-inhaled medical cannabis products to treat his respiratory symptoms, restore his sleep quality, and improve his quality of life.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Explain the pathophysiology of COPD and identify common management strategies
Discuss the potential benefits and limitations of medical cannabis as a treatment option for patients with COPD
Identify suitable candidates for medical cannabis treatment
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management of COPD
Devise treatment plans that consider patient safety and minimise risk
Offer effective patient education and treatment advice on the therapeutic use of medical cannabis
Rachel, a 40-year-old female, presents with migraines, insomnia and chronic abdominal pain secondary to a recent nephrectomy due to chronic kidney disease.After trying many medications with only minimal symptom relief, Rachel’s desperate to find an alternative solution.In this case study, we explore how Rachel’s team prescribed medical cannabis to help manage her pain and insomnia and improve her overall quality of life.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Explain how and why chronic renal kidney disease affects patients
Discuss the potential benefits and limitations of medical cannabis as a treatment option for chronic renal kidney disease, nephrectomy, migraines and nausea and vomiting
Identify suitable candidates for medical cannabis treatment
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management of chronic renal disease, nephrectomy, migraines, nausea and vomiting
Devise treatment plans that consider patient safety and minimise risk
Offer effective patient education and treatment advice on the therapeutic use of medical cannabis
Jen, a 21 year old woman experiences a couple of seizures per week due to photosensitive epilepsy.
This case study explores how Jen's team helped her reduce the duration and the frequency of her seizures with medical cannabis.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Demonstrate an understanding of safe prescribing and risks associated with medical cannabis and Epilepsy
Assess the suitability of cannabis treatment in patients with Epilepsy
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management
Monitor and provide titration advice around cannabinoid medicines
Apply critical safety considerations in patient centred care
Navigate the regulatory frameworks surrounding medical cannabis provision in Australia
46 year old Robert is dealing with a lot of stress at work. This is affecting his quality of sleep.
Explore how Robert's team helped him combat situational stress and prescribed medical cannabis to improve his overall sleep quality.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptomatic management of patients with insomnia
Identify suitable candidates for medical cannabis treatment
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management for insomnia
Apply critical safety considerations & provide patient education & treatment advice regarding MC treatment
Violet, a seventy-seven year old woman, is in palliative care and undergoing radiation therapy.
As she enters her end of life (EOL) period, she's looking to medical cannabis to improve her comfort and alleviate the pain caused by the side effects of the other therapies she's undergoing.
In this case study, we explore how Violet's team devised a suitable treatment plan that addressed her side effects and improved her quality of life (QOL) during her EOL period.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Define the palliative approach to care and outline key clinical assessments
Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptomatic management in palliative care
Identify suitable candidates for medical cannabis treatment
Apply critical safety considerations/risk mitigation strategies for patients using medical cannabis in palliative care
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in palliative care
Discuss product usage and critical safety considerations with patients in patient-centred care
Zoey, a 46 year old female is seeking treatment for her chemotherapy-related symptoms.
Zoey is currently undergoing chemotherapy as she was diagnosed with breast cancer at the start of 2023. There is risk of hepatic injury as medical cannabis and chemotherapy can both effect the liver.
This case study explores how Zoey's team managed the symptoms of her chronic pain, fatigue, low mood and lack of appetite using medical cannabis to to combat Zoey's chemotherapy symptoms and regain her sense of self.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptomatic management of chemotherapy and breast cancer
Identify suitable candidates for medical cannabis treatment
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management of Breast cancer and chemotherapy
Apply critical safety considerations & provide patient education & treatment advice regarding MC treatment
While medical cannabis is an effective treatment option for many patients, it’s considered an unapproved good on the TGA’s schedule of drugs. This course is designed to equip healthcare professionals with the skills, knowledge and confidence to navigate the TGA’s Special Access Scheme (SAS) and apply to prescribe medical cannabis to suitable individual patients on a case by case basis using the SAS-B pathway.
We’ll also delve into the broader legal and ethical considerations of prescribing medical cannabis as a treatment option, including risk-mitigation strategies so you can start prescribing medical cannabis to your eligible patients as soon as possible.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Define unapproved good
Describe different pathways for accessing and prescribing unapproved goods
Explain the differences and correct use of the SAS and Authorised prescriber pathways
Apply to prescribe medical cannabis for individual patients using the SAS-B pathway
Explain the legal and ethical considerations, and risk-mitigation strategies when prescribing medical cannabis via the SAS-B pathway
While medical cannabis is an effective treatment option for many patients, it’s considered an unapproved good on the TGA’s schedule of drugs. This course is designed to equip healthcare professionals with the skills, knowledge and confidence to navigate the TGA’s Special Access Scheme (SAS) and apply to prescribe medical cannabis to suitable individual patients on a case by case basis using the SAS-B pathway.
We’ll also delve into the broader legal and ethical considerations of prescribing medical cannabis as a treatment option, including risk-mitigation strategies so you can start prescribing medical cannabis to your eligible patients as soon as possible.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Define unapproved good
Describe different pathways for accessing and prescribing unapproved goods
Explain the differences and correct use of the SAS and Authorised prescriber pathways
Apply to prescribe medical cannabis for individual patients using the SAS-B pathway
Explain the legal and ethical considerations, and risk-mitigation strategies when prescribing medical cannabis via the SAS-B pathway
Lee has experienced anxiety for much of her adult life, but her symptoms have recently intensified—interfering with work, sleep, and daily functioning. Having previously trialled SSRIs with limited success, she is now exploring medical cannabis as a potential treatment option.
This case study follows Lee’s clinical assessment and treatment planning process, highlighting the key factors considered by her healthcare team in determining suitability for medical cannabis. Practitioners will examine how THC and CBD interact with anxiety symptoms, how patient history informs treatment planning, and what safety precautions are critical in minimising adverse effects—particularly with THC.
The module also explores regulatory considerations under the TGA framework and provides practical guidance on how to approach patient education and shared decision-making when discussing medical cannabis for anxiety management.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Discuss the relationship between THC, CBD and anxiety
Discuss the TGA requirements, potential benefits and limitations of medical cannabis as a treatment option for anxiety
Identify patients with anxiety who are suitable candidates for medical cannabis treatment
Collect detailed patient information
Apply critical safety considerations and provide patient education and treatment advice regarding medical cannabis treatment for anxiety
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management for anxiety
